| 000 | 01384 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513152925.0 | ||
| 264 | 0 | _c19981105 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0175-7598 | ||
| 024 | 7 |
_a10.1007/s002530051274 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCanyuk, B | |
| 245 | 0 | 0 |
_aBacterial complementation as a means to test enzyme-ligand interactions. _h[electronic resource] |
| 260 |
_bApplied microbiology and biotechnology _cAug 1998 |
||
| 300 |
_a181-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEscherichia coli _xgenetics |
| 650 | 0 | 4 | _aGenetic Complementation Test |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxanthine Phosphoribosyltransferase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aPlasmodium falciparum _xenzymology |
| 650 | 0 | 4 |
_aPurines _xpharmacology |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aTrypanosoma cruzi _xenzymology |
| 700 | 1 | _aCraig, S P | |
| 700 | 1 | _aEakin, A E | |
| 773 | 0 |
_tApplied microbiology and biotechnology _gvol. 50 _gno. 2 _gp. 181-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002530051274 _zAvailable from publisher's website |
| 999 |
_c9728514 _d9728514 |
||